L-Glutamine for Pediatric Sickle Cell Disease: Pharmacology, Mechanism of Action, Safety and Efficacy

EDUARD H. PANOSYAN

Open source

DOI
10.21873/invivo.14475
Published
2026-10-29
Container
In Vivo
Publisher
International Institute of Anticancer Research
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21873/invivo.14475,
  title = {L-Glutamine for Pediatric Sickle Cell Disease: Pharmacology, Mechanism of Action, Safety and Efficacy},
  author = {EDUARD H. PANOSYAN},
  year = {2026},
  journal = {In Vivo},
  doi = {10.21873/invivo.14475},
  url = {https://doi.org/10.21873/invivo.14475}
}

RIS

TY  - JOUR
TI  - L-Glutamine for Pediatric Sickle Cell Disease: Pharmacology, Mechanism of Action, Safety and Efficacy
AU  - EDUARD H. PANOSYAN
PY  - 2026
JO  - In Vivo
DO  - 10.21873/invivo.14475
UR  - https://doi.org/10.21873/invivo.14475
ER  - 

APA

PANOSYAN, E. H. (2026). L-Glutamine for Pediatric Sickle Cell Disease: Pharmacology, Mechanism of Action, Safety and Efficacy. In Vivo. https://doi.org/10.21873/invivo.14475

Source records